BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28734019)

  • 1. Association between androgen deprivation therapy and anxiety among 78 000 patients with localized prostate cancer.
    Dinh KT; Yang DD; Nead KT; Reznor G; Trinh QD; Nguyen PL
    Int J Urol; 2017 Oct; 24(10):743-748. PubMed ID: 28734019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Androgen Deprivation Therapy With Depression in Localized Prostate Cancer.
    Dinh KT; Reznor G; Muralidhar V; Mahal BA; Nezolosky MD; Choueiri TK; Hoffman KE; Hu JC; Sweeney CJ; Trinh QD; Nguyen PL
    J Clin Oncol; 2016 Jun; 34(16):1905-12. PubMed ID: 27069075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risks of Major Long-Term Side Effects Associated with Androgen-Deprivation Therapy in Men with Prostate Cancer.
    Nguyen C; Lairson DR; Swartz MD; Du XL
    Pharmacotherapy; 2018 Oct; 38(10):999-1009. PubMed ID: 30080934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen deprivation therapy and risk of rheumatoid arthritis in patients with localized prostate cancer.
    Yang DD; Krasnova A; Nead KT; Choueiri TK; Hu JC; Hoffman KE; Yu JB; Spratt DE; Feng FY; Trinh QD; Nguyen PL
    Ann Oncol; 2018 Feb; 29(2):386-391. PubMed ID: 29267861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between androgen deprivation therapy and community-acquired respiratory infections in patients with prostate cancer.
    Schmid M; Hanske J; Ravi P; Krishna N; Reznor G; Meyer CP; Fisch M; Noldus J; Nguyen PL; Trinh QD
    Int J Urol; 2016 Apr; 23(4):305-11. PubMed ID: 26763083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of colorectal cancer in men on long-term androgen deprivation therapy for prostate cancer.
    Gillessen S; Templeton A; Marra G; Kuo YF; Valtorta E; Shahinian VB
    J Natl Cancer Inst; 2010 Dec; 102(23):1760-70. PubMed ID: 21068432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of Declining Use and the Adverse Effect of Primary Androgen Deprivation on All-cause Mortality in Elderly Men with Prostate Cancer.
    Sammon JD; Abdollah F; Reznor G; Pucheril D; Choueiri TK; Hu JC; Kim SP; Schmid M; Sood A; Sun M; Kibel AS; Nguyen PL; Menon M; Trinh QD
    Eur Urol; 2015 Jul; 68(1):32-9. PubMed ID: 25457017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of dementia following androgen deprivation therapy for treatment of prostate cancer.
    Krasnova A; Epstein M; Marchese M; Dickerman BA; Cole AP; Lipsitz SR; Nguyen PL; Kibel AS; Choueiri TK; Basaria S; Mucci LA; Sun M; Trinh QD
    Prostate Cancer Prostatic Dis; 2020 Sep; 23(3):410-418. PubMed ID: 31784699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of androgen deprivation therapy use and fracture risk among elderly men with prostate cancer in the United States.
    Beebe-Dimmer JL; Cetin K; Shahinian V; Morgenstern H; Yee C; Schwartz KL; Acquavella J
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21(1):70-8. PubMed ID: 22114014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival following primary androgen deprivation therapy among men with localized prostate cancer.
    Lu-Yao GL; Albertsen PC; Moore DF; Shih W; Lin Y; DiPaola RS; Yao SL
    JAMA; 2008 Jul; 300(2):173-81. PubMed ID: 18612114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival Outcomes in Octogenarian and Nonagenarian Patients Treated with First-line Androgen Deprivation Therapy for Organ-confined Prostate Cancer.
    Dell'Oglio P; Bishr M; Boehm K; Trudeau V; Larcher A; Tian Z; Sosa J; Moschini M; Saad F; Capitanio U; Briganti A; Graefen M; Montorsi F; Karakiewicz PI
    Eur Urol Focus; 2018 Dec; 4(6):834-841. PubMed ID: 28753853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and predictive factors for the development of de novo psychiatric illness in patients receiving androgen deprivation therapy for prostate cancer.
    DiBlasio CJ; Hammett J; Malcolm JB; Judge BA; Womack JH; Kincade MC; Ogles ML; Mancini JG; Patterson AL; Wake RW; Derweesh IH
    Can J Urol; 2008 Oct; 15(5):4249-56; discussion 4256. PubMed ID: 18814813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of ischemic stroke after androgen deprivation therapy for prostate cancer in the Chinese population living in Hong Kong.
    Teoh JY; Chiu PK; Chan SY; Poon DM; Cheung HY; Hou SS; Ng CF
    Jpn J Clin Oncol; 2015 May; 45(5):483-7. PubMed ID: 25724216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of fracture after androgen deprivation for prostate cancer.
    Shahinian VB; Kuo YF; Freeman JL; Goodwin JS
    N Engl J Med; 2005 Jan; 352(2):154-64. PubMed ID: 15647578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of diabetes among patients receiving primary androgen deprivation therapy for clinically localized prostate cancer.
    Tsai HT; Keating NL; Van Den Eeden SK; Haque R; Cassidy-Bushrow AE; Ulcickas Yood M; Smith MR; Potosky AL
    J Urol; 2015 Jun; 193(6):1956-62. PubMed ID: 25524243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen Deprivation Therapy Use Increases the Risk of Heart Failure in Patients With Prostate Cancer: A Population-Based Cohort Study.
    Kao HH; Kao LT; Li IH; Pan KT; Shih JH; Chou YC; Wu ST
    J Clin Pharmacol; 2019 Mar; 59(3):335-343. PubMed ID: 30402905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality.
    Tsai HK; D'Amico AV; Sadetsky N; Chen MH; Carroll PR
    J Natl Cancer Inst; 2007 Oct; 99(20):1516-24. PubMed ID: 17925537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical androgen deprivation therapy and increased non-cancer mortality in non-metastatic prostate cancer patients aged ≥66 years.
    Abdollah F; Sammon JD; Reznor G; Sood A; Schmid M; Klett DE; Sun M; Aizer AA; Choueiri TK; Hu JC; Kim SP; Kibel AS; Nguyen PL; Menon M; Trinh QD
    Eur J Surg Oncol; 2015 Nov; 41(11):1529-39. PubMed ID: 26210655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer.
    Saigal CS; Gore JL; Krupski TL; Hanley J; Schonlau M; Litwin MS;
    Cancer; 2007 Oct; 110(7):1493-500. PubMed ID: 17657815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen Deprivation Therapy and the Risk of Anemia in Men with Prostate Cancer.
    Hicks BM; Klil-Drori AJ; Yin H; Campeau L; Azoulay L
    Epidemiology; 2017 Sep; 28(5):712-718. PubMed ID: 28768300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.